Takeda Pharmaceutical Company Limited (BVMF:TAKP34)

BVMF:TAKP34 Statistics

Total Valuation

BVMF:TAKP34 has a market cap or net worth of BRL 236.76 billion. The enterprise value is 391.11 billion.

Market Cap	236.76B
Enterprise Value	391.11B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	46.86%
Float	1.53B

Valuation Ratios

The trailing PE ratio is 198.77.

PE Ratio	198.77
Forward PE	n/a
PS Ratio	1.49
PB Ratio	0.92
P/TBV Ratio	n/a
P/FCF Ratio	6.46
P/OCF Ratio	5.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.66, with an EV/FCF ratio of 10.67.

EV / Earnings	328.36
EV / Sales	2.59
EV / EBITDA	9.66
EV / EBIT	23.77
EV / FCF	10.67

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.73.

Current Ratio	1.37
Quick Ratio	0.65
Debt / Equity	0.73
Debt / EBITDA	4.37
Debt / FCF	5.10
Interest Coverage	2.30

Financial Efficiency

Return on equity (ROE) is 0.47% and return on invested capital (ROIC) is 2.44%.

Return on Equity (ROE)	0.47%
Return on Assets (ROA)	2.09%
Return on Invested Capital (ROIC)	2.44%
Return on Capital Employed (ROCE)	3.94%
Revenue Per Employee	3.35M
Profits Per Employee	25,100
Employee Count	47,455
Asset Turnover	0.30
Inventory Turnover	1.24

Taxes

In the past 12 months, BVMF:TAKP34 has paid 2.33 billion in taxes.

Income Tax	2.33B
Effective Tax Rate	66.00%

Stock Price Statistics

The stock price has decreased by -11.05% in the last 52 weeks. The beta is 0.03, so BVMF:TAKP34's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-11.05%
50-Day Moving Average	80.66
200-Day Moving Average	77.24
Relative Strength Index (RSI)	37.92
Average Volume (20 Days)	50

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BVMF:TAKP34 had revenue of BRL 159.07 billion and earned 1.19 billion in profits. Earnings per share was 0.74.

Revenue	159.07B
Gross Profit	103.07B
Operating Income	17.51B
Pretax Income	3.53B
Net Income	1.19B
EBITDA	41.00B
EBIT	17.51B
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 24.54 billion in cash and 186.94 billion in debt, giving a net cash position of -162.40 billion.

Cash & Cash Equivalents	24.54B
Total Debt	186.94B
Net Cash	-162.40B
Net Cash Per Share	n/a
Equity (Book Value)	256.83B
Book Value Per Share	162.57
Working Capital	28.12B

Cash Flow

In the last 12 months, operating cash flow was 43.20 billion and capital expenditures -6.55 billion, giving a free cash flow of 36.65 billion.

Operating Cash Flow	43.20B
Capital Expenditures	-6.55B
Free Cash Flow	36.65B
FCF Per Share	n/a

Margins

Gross margin is 64.80%, with operating and profit margins of 11.01% and 0.75%.

Gross Margin	64.80%
Operating Margin	11.01%
Pretax Margin	2.22%
Profit Margin	0.75%
EBITDA Margin	25.77%
EBIT Margin	11.01%
FCF Margin	23.04%

Dividends & Yields

This stock pays an annual dividend of 2.96, which amounts to a dividend yield of 4.04%.

Dividend Per Share	2.96
Dividend Yield	4.04%
Dividend Growth (YoY)	5.60%
Years of Dividend Growth	3
Payout Ratio	935.06%
Buyback Yield	-0.65%
Shareholder Yield	3.39%
Earnings Yield	0.50%
FCF Yield	15.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:TAKP34 has an Altman Z-Score of 1.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	6